Back to search

Article

11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent

2024-05-10

Abstract excerpt

<h4>ABSTRACT</h4> Cortisol excess drives multiple adverse effects including hypertension, dyslipidemia, and delayed wound healing. Activation of cortisol by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) has shown promise as a therapeutic target for these comorbidities but clinical progress has been hampered by variable 11β-HSD1 inhibitor efficacy. Here, transcriptomic profiling of 11β-HSD1 target g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80088291-1280-5433-a151-333496c55255
DOI
10.1101/2024.05.10.24307180
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependentDOI 10.1101/2024.05.10.24307180
Select a neighboring publication to make it the new centre.